Preterm birth and its direct consequences are the leading cause of death for children under five years of age worldwide. Fifteen million infants are born prematurely every year, and about one million deaths are associated with prematurity. Societies around the globe are addressing this problem.
OxyPrem 1.4 is a next-generation medical device that monitors brain oxygen levels of preterm infants in real time, using harmless, non-invasive near-infrared light. It continuously measures local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
OxyPrem is reusable and sturdy, offering a feasible solution even for challenging environments. The team is working towards making the device fully compatible with standard hospital monitors. At Wyss Zurich, OxyPrem was introduced to clinical care on a wider scale; 30 hospitals in six European countries have been using OxyPrem to date as part of a large-scale multicenter clinical study that is accelerating the medical community’s efforts to make brain oxygen measurement a standard component of clinical care.